| Amir Darki, MD | |
|
2160 S 1st Ave Bldg 110, Division Of Cardiology,loyola University Medical Center, Maywood, IL 60153-3328 | |
| (708) 216-9447 | |
| Not Available |
| Full Name | Amir Darki |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 20 Years |
| Location | 2160 S 1st Ave Bldg 110, Maywood, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285835413 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 036118094 (Illinois) | Secondary |
| 207RI0011X | Internal Medicine - Interventional Cardiology | 036118094 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Loyola University Medical Center | Maywood, IL | Hospital |
| Gottlieb Memorial Hospital | Melrose park, IL | Hospital |
| Elmhurst Memorial Hospital | Elmhurst, IL | Hospital |
| Macneal Hospital | Berwyn, IL | Hospital |
| Central Dupage Hospital | Winfield, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Loyola University Medical Center | 3779488903 | 863 |
News Archive
According to a study recently accepted for publication by Environmental Health Perspectives, researchers found no correlation between specific human health effects in "watermen" (commercial fishermen) and low-level exposure to the dinoflagellate Pfiesteria in areas of the Chesapeake Bay.
New estimates suggest that 20 to 30 percent of opioid analgesic drugs prescribed for chronic pain are misused, while the rate of opioid addiction is approximately 10 percent, reports a study in the April issue of PAIN, the official journal of the International Association for the Study of Pain.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, announced positive preclinical results from its program targeting the gamma protein kinase C (PKC) pathway for the development of novel therapies for pain.
UCSF and SEEK Development, a global health and development consulting group based in Berlin, Germany, have launched an international partnership that aims to improve global health by helping to turn scientific evidence into policy and action. The Evidence-to-Policy Initiative, or E2Pi, officially launches this week in San Francisco and Berlin, Germany.
Allos Therapeutics has announced the presentation of new findings from its Phase 3 clinical trial of the investigational radiation sensitizer Efaproxyn (efaproxiral) in patients with brain metastases.
› Verified 4 days ago
| Entity Name | Loyola University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336159961 PECOS PAC ID: 3779488903 Enrollment ID: O20031202000027 |
News Archive
According to a study recently accepted for publication by Environmental Health Perspectives, researchers found no correlation between specific human health effects in "watermen" (commercial fishermen) and low-level exposure to the dinoflagellate Pfiesteria in areas of the Chesapeake Bay.
New estimates suggest that 20 to 30 percent of opioid analgesic drugs prescribed for chronic pain are misused, while the rate of opioid addiction is approximately 10 percent, reports a study in the April issue of PAIN, the official journal of the International Association for the Study of Pain.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, announced positive preclinical results from its program targeting the gamma protein kinase C (PKC) pathway for the development of novel therapies for pain.
UCSF and SEEK Development, a global health and development consulting group based in Berlin, Germany, have launched an international partnership that aims to improve global health by helping to turn scientific evidence into policy and action. The Evidence-to-Policy Initiative, or E2Pi, officially launches this week in San Francisco and Berlin, Germany.
Allos Therapeutics has announced the presentation of new findings from its Phase 3 clinical trial of the investigational radiation sensitizer Efaproxyn (efaproxiral) in patients with brain metastases.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amir Darki, MD 2160 S 1st Ave Bldg 110, Division Of Cardiology,loyola University Medical Center, Maywood, IL 60153-3328 Ph: (708) 216-9447 | Amir Darki, MD 2160 S 1st Ave Bldg 110, Division Of Cardiology,loyola University Medical Center, Maywood, IL 60153-3328 Ph: (708) 216-9447 |
News Archive
According to a study recently accepted for publication by Environmental Health Perspectives, researchers found no correlation between specific human health effects in "watermen" (commercial fishermen) and low-level exposure to the dinoflagellate Pfiesteria in areas of the Chesapeake Bay.
New estimates suggest that 20 to 30 percent of opioid analgesic drugs prescribed for chronic pain are misused, while the rate of opioid addiction is approximately 10 percent, reports a study in the April issue of PAIN, the official journal of the International Association for the Study of Pain.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, announced positive preclinical results from its program targeting the gamma protein kinase C (PKC) pathway for the development of novel therapies for pain.
UCSF and SEEK Development, a global health and development consulting group based in Berlin, Germany, have launched an international partnership that aims to improve global health by helping to turn scientific evidence into policy and action. The Evidence-to-Policy Initiative, or E2Pi, officially launches this week in San Francisco and Berlin, Germany.
Allos Therapeutics has announced the presentation of new findings from its Phase 3 clinical trial of the investigational radiation sensitizer Efaproxyn (efaproxiral) in patients with brain metastases.
› Verified 4 days ago
Dr. Cathryn T Sawalski, DO, MBA Internal Medicine Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 888-584-7888 | |
Suhana Elamsenthil, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 888-584-7888 | |
Holly Kramer, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2160 S First Ave, 101-1740 Loyola University Medical Center, Maywood, IL 60153 Phone: 708-216-9000 Fax: 708-216-9033 | |
Dr. Stephanie Bochen Tsai, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-9000 | |
Nicholas Poellinger, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 888-584-7888 | |
Sofia Ahmed, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-8757 | |
Shelly Lo, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Luh - North Ent., Rm. 7604, Maywood, IL 60153 Phone: 708-216-3304 Fax: 708-216-1259 |